Tacmoy, Angeline .

HRN: 23-54-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2023
CEFTRIAXONE 1G (VIAL)
08/16/2023
08/23/2023
IV
285mg
BID
TC Typhoid Fever, R/O Sepsis
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: